It seems that much of the upside for the vaccine play has been priced in. Cannot see very much more, other than one getting luckier than the other. It is a horse race right now, they are all neck and neck it seems. Astrazenica, which is not included, may be ahead right now; but not for long it seems.
Red Robin should be able to return to their 12% margins soon, their cost of goods and services should be lowered by an overall trend of lower beef and agricultural prices. This combined with more freely opened stores in major markets should allow them to profitability for Q3.
